Page last updated: 2024-10-17

phloroglucinol and Cerebral Infarction, Middle Cerebral Artery

phloroglucinol has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies

Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.

Research Excerpts

ExcerptRelevanceReference
"Hyperforin (0."1.48Hyperforin protects against acute cerebral ischemic injury through inhibition of interleukin-17A-mediated microglial activation. ( Liu, K; Ma, L; Pan, X; Wang, L; Zhou, F, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, L1
Pan, X1
Zhou, F1
Liu, K1
Wang, L1
Lin, Y1
Zhang, JC1
Fu, J1
Chen, F1
Wang, J1
Wu, ZL1
Yuan, SY1

Other Studies

2 other studies available for phloroglucinol and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Hyperforin protects against acute cerebral ischemic injury through inhibition of interleukin-17A-mediated microglial activation.
    Brain research, 2018, Jan-01, Volume: 1678

    Topics: Animals; Brain Infarction; Brain Injuries; Cytokines; Disease Models, Animal; Exploratory Behavior;

2018
Hyperforin attenuates brain damage induced by transient middle cerebral artery occlusion (MCAO) in rats via inhibition of TRPC6 channels degradation.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:2

    Topics: Animals; Apoptosis; Brain Ischemia; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Calpain; Cyc

2013